The influence of statin exposure on inflammatory markers in patients with early bacterial infection: pilot prospective cohort study

Manu Shankar-Hari, Antonia Donnelly, Ruxandra Pinto, Zaid Salih, Cathrine McKenzie, Marius Terblanche*, Neill K. J. Adhikari

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)
138 Downloads (Pure)

Abstract

Background: In the context of infection, progressive illness resulting in acute organ dysfunction is thought to be secondary to inflammatory response. Our aims were to determine risk factors for progressive illness following infection in a low-risk hospitalised cohort, including the impact of prior stain therapy.

Methods: We performed a prospective observational cohort study on two adult acute medical wards of a single tertiary academic hospital. We screened drug prescription charts of all adult acute medical admissions for inclusion criteria of inpatient administration of antibiotics for more than 24 hours for a microbiologically confirmed or clinically suspected infection. Patients were followed until admission to a high dependency unit (HDU) or intensive care unit (ICU), discharge from hospital, or to a maximum of 10 days. Outcomes were evolution of systemic inflammatory response syndrome (SIRS) criteria, white cell count and C-reactive protein measurements, and adverse clinical outcomes. We constructed multivariable models accounting for repeated within-patient measurements to determine associations between a priori selected predictors (days since admission, age, gender, Charlson score, prior statin exposure) and selected outcomes.

Results: We enrolled 209 patients; 27.8% were statin users and the commonest infection was pneumonia (51.0%). Most (88.0%) had at least 1 SIRS criterion on admission, and 76 (37.3%) manifested additional SIRS criteria over time. Risks of admission to HDU/ ICU (3.3%) and of 30-day mortality (5.7%) were low. The proportion of patients with at least 1 SIRS criterion, mean CRP, and mean WBC all decreased over time. Multivariable regression models identified days since hospital admission as the only variable associated with daily presence of SIRS criteria, WCC, or CRP (adjusted OR <1 and p <0.0001 in all analyses). Statin exposure was not a significant predictor.

Conclusions: This cohort of ward patients treated for infection had a low risk of clinical deterioration, inflammatory markers improved over time, and statin exposure was not associated with any outcome. Future larger studies may identify risk factors for progression of illness in this population and plausible surrogate endpoints for evaluation in clinical trials.

Original languageEnglish
Article number106
Number of pages8
JournalAnesthesiology
Volume14
DOIs
Publication statusPublished - 19 Nov 2014

Keywords

  • Sepsis
  • Biomarkers
  • Surrogate end-points
  • Progression of illness
  • C-REACTIVE PROTEIN
  • RESPONSE SYNDROME
  • SEVERE SEPSIS
  • ORGAN FAILURE
  • THERAPY
  • EPIDEMIOLOGY
  • PNEUMONIA
  • TRIAL
  • CARE

Fingerprint

Dive into the research topics of 'The influence of statin exposure on inflammatory markers in patients with early bacterial infection: pilot prospective cohort study'. Together they form a unique fingerprint.

Cite this